JW Pharmaceutical Corporation (001060.KS)
001060.KS Stock Price Chart
Explore JW Pharmaceutical Corporation interactive price chart. Choose custom timeframes to analyze 001060.KS price movements and trends.
001060.KS Company Profile
Discover essential business fundamentals and corporate details for JW Pharmaceutical Corporation (001060.KS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
29 Sept 2005
Employees
1.06K
Website
https://www.jw-pharma.co.krCEO
Young-Sub Shin
Description
JW Pharmaceutical Corporation develops, manufactures, and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cardiovascular, gastrointestinal, urinary, oral hypoglycemic, antibiotics, anti-fungal, Ob and Gy, renal, CNS, anti-anemic, respiratory, rheumatic arthritis, anticancer, anesthetic, antidotes, amino acids, TPN, and others. The company was founded in 1945 and is headquartered in Seoul, South Korea.
001060.KS Financial Timeline
Browse a chronological timeline of JW Pharmaceutical Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 May 2026
Upcoming earnings on 5 Feb 2026
Upcoming earnings on 4 Nov 2025
Earnings released on 31 Jul 2025
EPS came in at -₩80.39 , while revenue for the quarter reached ₩191.10B , missing expectations by -0.60%.
Earnings released on 7 May 2025
EPS came in at ₩714.00 falling short of the estimated ₩769.75 by -7.24%, while revenue for the quarter reached ₩185.24B , beating expectations by +1.11%.
Earnings released on 4 Feb 2025
EPS came in at ₩712.00 falling short of the estimated ₩1.38K by -48.25%, while revenue for the quarter reached ₩187.85B , missing expectations by -1.08%.
Dividend declared on 27 Dec 2024
A dividend of ₩450.00 per share was announced, adjusted to ₩450.00. The dividend was paid on 1 Apr 2025.
Earnings released on 6 Nov 2024
EPS came in at ₩807.00 surpassing the estimated ₩614.74 by +31.28%, while revenue for the quarter reached ₩178.66B , missing expectations by -4.28%.
Earnings released on 1 Aug 2024
EPS came in at ₩346.00 falling short of the estimated ₩527.05 by -34.35%, while revenue for the quarter reached ₩172.28B , missing expectations by -9.76%.
Earnings released on 8 May 2024
EPS came in at ₩816.00 surpassing the estimated ₩577.17 by +41.38%, while revenue for the quarter reached ₩180.59B , missing expectations by -4.94%.
Earnings released on 5 Feb 2024
EPS came in at ₩1.09K surpassing the estimated ₩1.06K by +2.78%, while revenue for the quarter reached ₩205.02B , missing expectations by -0.81%.
Dividend declared on 27 Dec 2023
A dividend of ₩400.00 per share was announced, adjusted to ₩400.00. The dividend was paid on 1 Apr 2024.
Stock split effective on 27 Dec 2023
Shares were split 51 : 50 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 8 Nov 2023
EPS came in at -₩742.00 falling short of the estimated ₩663.48 by -211.83%, while revenue for the quarter reached ₩184.20B , missing expectations by -2.77%.
Earnings released on 9 Aug 2023
EPS came in at ₩542.00 falling short of the estimated ₩606.48 by -10.63%, while revenue for the quarter reached ₩185.92B , missing expectations by -0.13%.
Earnings released on 15 May 2023
EPS came in at ₩665.07 , while revenue for the quarter reached ₩173.38B , missing expectations by -1.54%.
Stock split effective on 13 Mar 2023
Shares were split 103 : 100 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 8 Feb 2023
EPS came in at ₩558.33 , while revenue for the quarter reached ₩193.16B , beating expectations by +4.63%.
Dividend declared on 28 Dec 2022
A dividend of ₩375.00 per share was announced, adjusted to ₩356.94. The dividend was paid on 28 Apr 2023.
Earnings released on 9 Nov 2022
EPS came in at ₩367.58 , while revenue for the quarter reached ₩169.85B , beating expectations by +1.63%.
Earnings released on 16 Aug 2022
EPS came in at ₩43.55 , while revenue for the quarter reached ₩165.00B , beating expectations by +1.11%.
Earnings released on 10 May 2022
EPS came in at ₩424.91 , while revenue for the quarter reached ₩156.34B , missing expectations by -0.23%.
Earnings released on 22 Mar 2022
EPS came in at -₩276.66 , while revenue for the quarter reached ₩169.47B .
Dividend declared on 29 Dec 2021
A dividend of ₩325.00 per share was announced, adjusted to ₩309.35. The dividend was paid on 29 Apr 2022.
Stock split effective on 29 Dec 2021
Shares were split 103 : 100 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 Nov 2021
EPS came in at ₩206.43 , while revenue for the quarter reached ₩148.99B .
Earnings released on 18 Aug 2021
EPS came in at -₩136.68 , while revenue for the quarter reached ₩146.03B .
Earnings released on 18 May 2021
EPS came in at ₩163.07 , while revenue for the quarter reached ₩142.09B .
Earnings released on 18 Mar 2021
EPS came in at -₩326.52 , while revenue for the quarter reached ₩144.71B .
Dividend declared on 29 Dec 2020
A dividend of ₩315.53 per share was announced, adjusted to ₩291.59. The dividend was paid on 23 Apr 2021.
Stock split effective on 29 Dec 2020
Shares were split 103 : 100 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 16 Nov 2020
EPS came in at ₩118.97 , while revenue for the quarter reached ₩137.14B .
001060.KS Stock Performance
Access detailed 001060.KS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.